These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The Association of Five-Year Changes in the Levels of N-Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide (NT-proBNP) with Subsequent Heart Failure and Death in Patients with Stable Coronary Artery Disease: The Heart and Soul Study. Mishra RK, Judson G, Christenson RH, DeFilippi C, Wu AHB, Whooley MA. Cardiology; 2017; 137(4):201-206. PubMed ID: 28445886 [Abstract] [Full Text] [Related]
4. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population. Zhu Q, Xiao W, Bai Y, Ye P, Luo L, Gao P, Wu H, Bai J. Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868 [Abstract] [Full Text] [Related]
5. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure. Alehagen U, Dahlström U, Rehfeld JF, Goetze JP. JAMA; 2011 May 25; 305(20):2088-95. PubMed ID: 21610241 [Abstract] [Full Text] [Related]
8. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery. Schouten O, Hoeks SE, Goei D, Bax JJ, Verhagen HJ, Poldermans D. J Vasc Surg; 2009 Feb 25; 49(2):435-41; discussion 441-2. PubMed ID: 19028043 [Abstract] [Full Text] [Related]
10. The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study. West MJ, Nestel PJ, Kirby AC, Schnabel R, Sullivan D, Simes RJ, Pollicino C, Lubos E, Münzel TF, White HD, Tonkin AM, Bickel C, Tiret L, Blankenberg S, LIPID Study Investigators. Eur Heart J; 2008 Apr 25; 29(7):923-31. PubMed ID: 18296678 [Abstract] [Full Text] [Related]
11. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease. Baggen VJ, van den Bosch AE, Eindhoven JA, Schut AW, Cuypers JA, Witsenburg M, de Waart M, van Schaik RH, Zijlstra F, Boersma E, Roos-Hesselink JW. Circulation; 2017 Jan 17; 135(3):264-279. PubMed ID: 27832613 [Abstract] [Full Text] [Related]
12. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction. Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E. Am J Cardiol; 2008 Sep 15; 102(6):733-7. PubMed ID: 18773998 [Abstract] [Full Text] [Related]
13. Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old. Poortvliet R, de Craen A, Gussekloo J, de Ruijter W. Age Ageing; 2015 Sep 15; 44(5):841-7. PubMed ID: 26209786 [Abstract] [Full Text] [Related]
15. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus. Wolsk E, Claggett B, Pfeffer MA, Diaz R, Dickstein K, Gerstein HC, Lawson FC, Lewis EF, Maggioni AP, McMurray JJV, Probstfield JL, Riddle MC, Solomon SD, Tardif JC, Køber L. J Am Heart Assoc; 2017 May 29; 6(6):. PubMed ID: 28554908 [Abstract] [Full Text] [Related]
17. Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial. Jarai R, Huber K, Bogaerts K, Droogne W, Ezekowitz J, Granger CB, Sinnaeve PR, Ross AM, Zeymer U, Armstrong PW, Van de Werf FJ, ASSENT IV-PCI investigators. Am Heart J; 2010 Jan 29; 159(1):131-40. PubMed ID: 20102879 [Abstract] [Full Text] [Related]